Trials / Unknown
UnknownNCT05672732
Assessment of Clinical Trial Experiences of Alzheimer's Disease Patients
In Depth Observational Clinical Trial Assessing Experiences of Alzheimer's Disease Patients To Determine Trial Attributes Affecting Completion Rates For Specific Demographic Groups
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Power Life Sciences Inc. · Industry
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Taking part in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This study will admit a wide range of data on the clinical trial experience of Alzheimer's Disease patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Alzheimer's Disease patients.
Conditions
Timeline
- Start date
- 2024-02-01
- Primary completion
- 2025-02-01
- Completion
- 2026-02-01
- First posted
- 2023-01-05
- Last updated
- 2023-06-18
Source: ClinicalTrials.gov record NCT05672732. Inclusion in this directory is not an endorsement.